| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/10/2011 | CA2361249C Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/10/2011 | CA2248016C Direct molecular diagnosis of friedreich ataxia |
| 05/05/2011 | WO2011050808A1 Use of carbamylated erythropoietin for the treatment of friedreich's ataxia |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105555 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands |
| 05/05/2011 | US20110105553 New classes of gabaa/bzr ligands |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105403 Peptides |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105390 Selection and treatment of patients suffering from wasting |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | CA2777827A1 Alleviating oxidative stress disorders with pufa derivatives |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040558A Substituted bicyclo(3,3,1)nonane ether compound and application thereof |
| 05/04/2011 | CN102039002A Leg and foot fabric capable of promoting blood circulation and relieving fatigue |
| 05/04/2011 | CN101007112B A traditional Chinese medicine for treating myasthenia gravis and its producing method |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935690 Pharmaceutical composition |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011048350A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110097427 Molecular Targets and Dietary Modulators of Exercise-Induced Muscle Damage |
| 04/28/2011 | US20110097381 Conformable tissue repair implant capable of injection delivery |
| 04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2313414A2 Kinase inhibitors and methods of use |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036972A Treatment of duchenne muscular dystrophy |
| 04/27/2011 | CN102029015A Blood circulation-promoting and cold-protecting health care bag |
| 04/27/2011 | CN102028949A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 04/27/2011 | CN102028872A Orally-taken traditional Chinese medicine for treating acute lumbar muscle sprain and preparation method thereof |
| 04/27/2011 | CN102028729A Method for simultaneously extracting caulis trachelospermi total lignan and total flavone |
| 04/27/2011 | CN102028630A Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener |
| 04/27/2011 | CN101575341B Amidocyanogen amido xanthone pyridine derivant, and preparation method and application thereof |
| 04/27/2011 | CN101209109B Composition with muscle-increasing function and beverage prepared thereby |
| 04/27/2011 | CN101143192B Therapeutic gastrodia extracts |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/21/2011 | WO2011047093A2 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092587 Branched-chain amino acid composition for improving skeletal muscle protein metabolism |
| 04/21/2011 | US20110092559 Pyrrole and pyrazole daao inhibitors |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092525 Gabaa receptor modulators |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091585 Herbal compositions and methods for enhancing vital energy and athletic performance |
| 04/21/2011 | US20110091503 Therapeutic composition with a botulinum neurotoxin |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091455 Antibodies to myostatin |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091433 Treatment using reprogrammed mature adult cells |
| 04/21/2011 | US20110091407 Polymer derived from linear polyethylenimine for gene transfer |
| 04/21/2011 | CA2777663A1 Method for treating chronic nerve tissue injury using a cell therapy strategy |
| 04/21/2011 | CA2777401A1 Stem cells for musculoskeletal tissue repair |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2311440A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310037A2 Conglutin-gamma as medicament and diet supplement |
| 04/20/2011 | EP2310022A1 Topical medicament |
| 04/20/2011 | CN1985833B Use of estrone derivative EA204 in preparing vascular smooth muscle relaxant |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102018863A Medicine paste with functions of diminishing inflammation, relieving pain, activating blood circulation and dissipating blood stasis and manufacturing method thereof |
| 04/20/2011 | CN102018818A Medicine for treating myasthenia gravis |
| 04/20/2011 | CN102018744A Formula for treating hiccough |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN101612178B Carrot seed volatile oil preparation method and application thereof |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |